Market Overview:
The global osseointegration implants market reached a value of US$ 5,928.0 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8,747.7 Million by 2027 exhibiting a growth rate (CAGR) of 6.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Osseointegration implants refer to a type of endosteal implants that contain pores in which osteoblasts and supporting connective tissues can migrate. They are manufactured using ceramics, biostable polymers, and metals, such as titanium, chromium, tantalum, cobalt, and stainless steel. They allow a direct structural connection between the bone and implant without interposed connective tissues and ingrowth or interdigitation of the newly formed lamellar bone. They also offer fewer side effects, enhanced stability, and reduced post-surgery recovery time than traditional procedures. As a result, osseointegration implants are widely used for dental implants, bone-anchored hearing aids, endoprostheses, spinal instrumentation hardware, and knee and joint replacement.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Osseointegration Implants Market Trends:
The increasing cases of dental disorders on account of the aging population, inadequate exposure to fluoride, and poor oral hygiene represent the primary factors driving the market growth. Additionally, the rising fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis have strengthened the need for joint and knee replacement surgeries. This, in line with the shifting consumer preferences toward minimally invasive surgeries (MIS), is catalyzing the market growth. Besides this, the widespread prevalence of chronic diseases, such as obesity and degenerative spinal conditions, due to unhealthy eating habits, sedentary lifestyles, high alcohol consumption, and smoking is augmenting the demand for osseointegration implants. Furthermore, the leading players are heavily investing in research and development (R&D) activities to launch innovative product variants to expand their product portfolio and maintain a competitive edge. Other factors, including the rising adoption of cosmetic dentistry, improving healthcare infrastructure, inflating consumer disposable incomes, supportive government initiatives, and favorable reimbursement policies, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global osseointegration implants market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, material and end user.
Breakup by Product:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Bone-Anchored Prostheses
- Dental Implants
Breakup by Material:
- Metallic
- Ceramic
- Polymeric
- Biomaterials
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Dental Clinics
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bicon LLC, CONMED Corporation, Demant A/S, Dentsply Sirona Inc., Envista Holdings Corporation, Henry Schein Inc., Institut Straumann AG, Integrum AB, Medtronic plc, NuVasive Inc., Osstem Implant Co. Ltd., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Million |
Segment Coverage |
Product, Material, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Bicon LLC, CONMED Corporation, Demant A/S, Dentsply Sirona Inc., Envista Holdings Corporation, Henry Schein Inc., Institut Straumann AG, Integrum AB, Medtronic plc, NuVasive Inc., Osstem Implant Co. Ltd., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |